BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36181946)

  • 21. Development, phenotypes of immune cells in BTBR T
    Uddin MN; Yao Y; Manley K; Lawrence DA
    Cell Immunol; 2020 Dec; 358():104223. PubMed ID: 33137646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroanatomical analysis of the BTBR mouse model of autism using magnetic resonance imaging and diffusion tensor imaging.
    Ellegood J; Babineau BA; Henkelman RM; Lerch JP; Crawley JN
    Neuroimage; 2013 Apr; 70():288-300. PubMed ID: 23275046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AMPAKINE enhancement of social interaction in the BTBR mouse model of autism.
    Silverman JL; Oliver CF; Karras MN; Gastrell PT; Crawley JN
    Neuropharmacology; 2013 Jan; 64(1):268-82. PubMed ID: 22801296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autism-like behavioral phenotypes in BTBR T+tf/J mice.
    McFarlane HG; Kusek GK; Yang M; Phoenix JL; Bolivar VJ; Crawley JN
    Genes Brain Behav; 2008 Mar; 7(2):152-63. PubMed ID: 17559418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low home cage social behaviors in BTBR T+tf/J mice during juvenile development.
    Babineau BA; Yang M; Berman RF; Crawley JN
    Physiol Behav; 2013 Apr; 114-115():49-54. PubMed ID: 23510981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Revisiting sociability: Factors facilitating approach and avoidance during the three-chamber test.
    Arakawa H
    Physiol Behav; 2023 Dec; 272():114373. PubMed ID: 37805136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism.
    Chadman KK
    Pharmacol Biochem Behav; 2011 Jan; 97(3):586-94. PubMed ID: 20863848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral assessments of BTBR T+Itpr3tf/J mice by tests of object attention and elevated open platform: Implications for an animal model of psychiatric comorbidity in autism.
    Chao OY; Yunger R; Yang YM
    Behav Brain Res; 2018 Jul; 347():140-147. PubMed ID: 29545145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of behavioral phenotypes in the BTBR T
    Endo N; Makinodan M; Somayama N; Komori T; Kishimoto T; Nishi M
    Exp Anim; 2019 Aug; 68(3):319-330. PubMed ID: 30905912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP.
    Silverman JL; Tolu SS; Barkan CL; Crawley JN
    Neuropsychopharmacology; 2010 Mar; 35(4):976-89. PubMed ID: 20032969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ketogenic diet restores aberrant cortical motor maps and excitation-to-inhibition imbalance in the BTBR mouse model of autism spectrum disorder.
    Smith J; Rho JM; Teskey GC
    Behav Brain Res; 2016 May; 304():67-70. PubMed ID: 26876011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonergic circuit dysregulation underlying autism-related phenotypes in BTBR mouse model of autism.
    Higuchi Y; Tada T; Nakachi T; Arakawa H
    Neuropharmacology; 2023 Oct; 237():109634. PubMed ID: 37301467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the neuroactive steroid ganaxolone on social and repetitive behaviors in the BTBR mouse model of autism.
    Kazdoba TM; Hagerman RJ; Zolkowska D; Rogawski MA; Crawley JN
    Psychopharmacology (Berl); 2016 Jan; 233(2):309-23. PubMed ID: 26525567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the Partial M1 Muscarinic Cholinergic Receptor Agonist CDD-0102A on Stereotyped Motor Behaviors and Reversal Learning in the BTBR Mouse Model of Autism.
    Athnaiel O; Job GA; Ocampo R; Teneqexhi P; Messer WS; Ragozzino ME
    Int J Neuropsychopharmacol; 2022 Jan; 25(1):64-74. PubMed ID: 34791301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of operant social motivation paradigms using BTBR T+tf/J and C57BL/6J inbred mouse strains.
    Martin L; Sample H; Gregg M; Wood C
    Brain Behav; 2014 Sep; 4(5):754-64. PubMed ID: 25328850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatosensorimotor and Odor Modification, Along with Serotonergic Processes Underlying the Social Deficits in BTBR T+ Itpr3
    Arakawa H
    Neuroscience; 2020 Oct; 445():144-162. PubMed ID: 32061779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Nicotinic Receptors in the Attenuation of Autism-Related Behaviors in a Murine BTBR T + tf/J Autistic Model.
    Mahmood HM; Aldhalaan HM; Alshammari TK; Alqasem MA; Alshammari MA; Albekairi NA; AlSharari SD
    Autism Res; 2020 Aug; 13(8):1311-1334. PubMed ID: 32691528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of social deficits and repetitive behaviors in a mouse model of autism: the role of the nicotinic cholinergic system.
    Wang L; Almeida LE; Spornick NA; Kenyon N; Kamimura S; Khaibullina A; Nouraie M; Quezado ZM
    Psychopharmacology (Berl); 2015 Dec; 232(23):4303-16. PubMed ID: 26337613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GW4064 Alters Gut Microbiota Composition and Counteracts Autism-Associated Behaviors in BTBR T+tf/J Mice.
    Liu J; Liu C; Gao Z; Zhou L; Gao J; Luo Y; Liu T; Fan X
    Front Cell Infect Microbiol; 2022; 12():911259. PubMed ID: 35811667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epothilone D Modulates Autism-like Behaviors in the BTBR Mouse Model of Autism Spectrum Disorder.
    Zhao M; Chang Q; Yang H; Wang M; Liu Y; Lv N; Lei Q; Wei H
    Neuroscience; 2022 May; 490():171-181. PubMed ID: 35227832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.